Prelude Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,029
| Closed | -$66K | – | 1280 |
|
|
2020
Q3 | $66K | Buy |
5,029
+4,762
| +1,784% | +$62.5K | ﹤0.01% | 801 |
|
|
2020
Q2 | $3K | Buy |
+267
| New | +$3K | ﹤0.01% | 1207 |
|
|
2019
Q1 | – | Sell |
-282
| Closed | -$8K | – | 1597 |
|
|
2018
Q4 | $8K | Buy |
282
+118
| +72% | +$3.35K | ﹤0.01% | 1069 |
|
|
2018
Q3 | $8K | Sell |
164
-253
| -61% | -$12.3K | ﹤0.01% | 1175 |
|
|
2018
Q2 | $16K | Buy |
+417
| New | +$16K | ﹤0.01% | 1116 |
|
|
2017
Q3 | – | Sell |
-12,092
| Closed | -$312K | – | 1678 |
|
|
2017
Q2 | $312K | Sell |
12,092
-30,018
| -71% | -$775K | 0.03% | 398 |
|
|
2017
Q1 | $809K | Buy |
42,110
+10,211
| +32% | +$196K | 0.08% | 239 |
|
|
2016
Q4 | $532K | Buy |
31,899
+24,491
| +331% | +$408K | 0.06% | 283 |
|
|
2016
Q3 | $152K | Buy |
7,408
+2,808
| +61% | +$57.6K | 0.02% | 602 |
|
|
2016
Q2 | $141K | Buy |
+4,600
| New | +$141K | 0.02% | 577 |
|
|
2015
Q3 | – | Sell |
-550
| Closed | -$19K | – | 1586 |
|
|
2015
Q2 | $19K | Sell |
550
-550
| -50% | -$19K | ﹤0.01% | 1298 |
|
|
2015
Q1 | $39K | Buy |
+1,100
| New | +$39K | 0.01% | 1393 |
|
|
2014
Q4 | – | Sell |
-12,521
| Closed | -$483K | – | 1949 |
|
|
2014
Q3 | $483K | Sell |
12,521
-515
| -4% | -$19.9K | 0.07% | 348 |
|
|
2014
Q2 | $507K | Buy |
13,036
+1,921
| +17% | +$74.7K | 0.07% | 326 |
|
|
2014
Q1 | $380K | Buy |
11,115
+1,090
| +11% | +$37.3K | 0.05% | 444 |
|
|
2013
Q4 | $210K | Buy |
10,025
+2,863
| +40% | +$60K | 0.03% | 550 |
|
|
2013
Q3 | $168K | Buy |
+7,162
| New | +$168K | 0.03% | 512 |
|